Healthcare -
Biotechnology - NASDAQ - US
$ 30.75
-0.646 %
$ 13.7 B
Market Cap
12.11
P/E
RPRX - OPERATING INCOME
Operating Income RPRX - Royalty Pharma plc
1.49 B
LAST VALUE
2.12%
2 YEAR CAGR
1.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR